Noninvasive quantitative testing of liver function using ultrasonography in patients with cirrhosis

Hepato-Gastroenterology

Volumn 53, Issue 67, 2006, Pages 15-20

  Yan, Guo Zhen ^a   Duan, Yun You ^a   Ruan, Li Tao ^a   Cao, Tie Sheng ^a   Yuan, Li Jun ^a   Yang, Yi Lin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cirrhosis; Hepatic fibrosis; Ultrasound diagnosis

Indexed keywords

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEPATIC VEIN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 33344463896     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Imbert-Bismet F, Ratziu V, Pieroni L, et al: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection in a prospective study. Lancet 2001; 357:1069-1075.
2. Takahara T, Furui K, Yata Y, et al: Dual expression of matrix protease-2 and membrance type I-matrix proteinase in fibrotic human liver. Hepatology 1997; 26:1521-1529.
3. Frieman SL: Molecular regulation of hepatic fibrosis and integrated cellular response to tissue injury. J Biol Chem 2000; 275:2247-2250.
4. Hepatic fibrosis study group of Chinese liver diseases: Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis. Chin J Hepatol 2002; 10(5):327-328.
5. Gaiani S, Gramatieri L, Venturoli N, et al: What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997; 27:979-985.
6. Rachfal AW, Brigstock DR: Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003; 26:1-9.
7. Czaja AJ, Carpenter HA: Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004; 40:646-652.
8. Aube C, Oberti F, Korali N, et al: Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30:472-478.
9. Massarrat S, Fallahazad V, Kamalian N, et al: Clinical, biochemical and imaging-verified regression of hepatitis B-induced cirrhosis. Liver International 2004; 24:105-109.
10. Meziri M, Pereira W, Abdelwahab A, et al: In vitro chronic hepatic disease, characterization with a multiparametric ultrasonic approach. Ultrasonics 2005; 43(5):305-313.
11. Colli A, Fraquelli M, Andreoletti M, et al: Severe liver fibrosis or cirrhosis: accuracy of US for detection-analysis of 300 cases. Radiology 227:89-94.
12. Tchelepi H, Rulls PW, Radin R, et al: Sonography of diffuse liver disease. J Ultrasound Med 2002; 21:1023-1032.
13. Hübner GH, Steudel N, Kleber G, et al: Hepatic arterial flow velocities: assessment by transcutaneous and intravascular Doppler sonography. J Hepatol 2000; 32:893-899.
14. Bolognesi M, Sacerdoti D, Bombonato G, et al: Splenic impedance indices: a useful method to monitor patients after liver transplantation? Hepatology 1998; 27:674-678.
15. Lindner JR: Evolving applications for contrast ultrasound. Am J Cardiol 2002; 90(18):72-80.